424 filings
Page 5 of 22
FWP
a91t97 e3mwnc8
13 Nov 20
Free writing prospectus
6:09am
8-K
yk2h09fzexn4cgi
13 Nov 20
Other Events
6:07am
424B5
03tc yi3vz5yk
12 Nov 20
Prospectus supplement for primary offering
4:57pm
8-K
dn8y003
9 Nov 20
Cassava Sciences Reports Third Quarter 2020 Financial Results
8:30am
8-K
pbaaj
4 Nov 20
Regulation FD Disclosure
5:02pm
8-K
szg9sk17mpc 9wkpwdvs
14 Sep 20
Regulation FD Disclosure
4:01pm
8-K
qd6mta
10 Sep 20
Entry into a Material Definitive Agreement
4:06pm
8-K
jpgcgzt35s 85ew62uv
1 Sep 20
Departure of Directors or Certain Officers
5:00pm
8-K
elhza5 7r
12 Aug 20
Cassava Sciences Announces Second Quarter 2020 Financial Results and Mid-year Business Review
8:30am
8-K
ck4ktk
15 Jul 20
Regulation FD Disclosure
4:46pm
8-K
y16xzngd9p6k atn
19 Jun 20
Departure of Directors or Certain Officers
4:44pm
8-K
4nt9ix ar
3 Jun 20
Regulation FD Disclosure
5:29pm
8-K
un1ky2el w4ajvo31
15 May 20
Top-line Results from a Phase 2b Study of PTI-125 in Alzheimer’s Disease Does Not Meet Primary Endpoint
8:20am
8-K
rkm9n9lgzxukj nhotvq
11 May 20
Submission of Matters to a Vote of Security Holders
4:08pm
8-K
j98lbwahf4dqfcyf
6 May 20
Cassava Sciences Reports First Quarter 2020 Financial Results and Provides Business Update
8:16am
EFFECT
v4b3 llvb9ufl
6 May 20
Notice of effectiveness
12:15am
424B2
u40foqw
5 May 20
Prospectus for primary offering
4:38pm